Literature DB >> 2589960

Current results of treatment for distant metastatic well-differentiated thyroid carcinoma.

W J Wood1, S E Singletary, R C Hickey.   

Abstract

Between 1960 and 1986, 37 patients were treated at M. D. Anderson Hospital and Tumor Institute, Houston, Tex, for metastases beyond the thyrocervical region arising from well-differentiated thyroid carcinomas. Patient, tumor, and treatment factors were analyzed in this group for their influence on survival. No specific factors achieved statistical significance; however, patients having more than one site of metastasis and patients whose metastases arose less than 5 years after treatment of the primary tumor tended to have shorter overall survival times. More than one modality of treatment was used in the majority of patients. Complete surgical resection of metastases offered the best chance for prolonged survival and palliation. With long survival times being the rule, several treatment modalities are often required to provide continuous palliation.

Entities:  

Mesh:

Year:  1989        PMID: 2589960     DOI: 10.1001/archsurg.1989.01410120020005

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  12 in total

Review 1.  Endemic goiter and endemic thyroid disorders.

Authors:  E Gaitan; N C Nelson; G V Poole
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

2.  Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.

Authors:  Carlos A Benbassat; Sara Mechlis-Frish; Dania Hirsch
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

3.  Long-Term Outcome of Follicular Thyroid Carcinoma in Patients Undergoing Surgical Intervention for Skeletal Metastases.

Authors:  Anjali Mishra; Chitresh Kumar; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

Review 4.  Metastatic papillary thyroid carcinoma to the maxilla: case report and literature review.

Authors:  Nikolaos G Nikitakis; Angeliki Polymeri; Antonis Polymeris; Alexandra Sklavounou
Journal:  Head Neck Pathol       Date:  2011-12-30

Review 5.  Solitary liver metastasis from Hürthle cell thyroid cancer: a case report and review of the literature.

Authors:  M Salvatori; G Perotti; V Rufini; M L Maussier; V Summaria; G Fadda; L Troncone
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

6.  Clinical Status and Treatment of Liver Metastasis of Differentiated Thyroid Cancer Using Tyrosine Kinase Inhibitors.

Authors:  Yoshiyuki Saito; Kiminori Sugino; Hiroshi Takami; Kenichi Matsuzu; Takashi Uruno; Keiko Ohkuwa; Wataru Kitagawa; Mitsuji Nagahama; Hirofumi Kawakubo; Koichi Ito; Yuko Kitagawa
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

7.  Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma.

Authors:  Seyfettin Ilgan; A Ozgur Karacalioglu; Yuksel Pabuscu; G Kaan Atac; Nuri Arslan; Emel Ozturk; Bengul Gunalp; M Ali Ozguven
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-05       Impact factor: 9.236

Review 8.  Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature.

Authors:  T Negele; G Meisetschläger; T Brückner; K Scheidhauer; M Schwaiger; H Vogelsang
Journal:  Langenbecks Arch Surg       Date:  2006-02-21       Impact factor: 3.445

9.  Resection of metastatic thyroid carcinomas to the liver and the kidney: report of a case.

Authors:  G E Tur; Y Asanuma; T Sato; H Kotanagi; M Sageshima; Z Yong-Jie; K Koyama
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

10.  Laparoscopic partial nephrectomy of thyroid cancer metastasis: case report and review of the literature.

Authors:  Giovanni Cochetti; Efisio Puxeddu; Michele Del Zingaro; Francesco D'Amico; Emanuele Cottini; Francesco Barillaro; Ettore Mearini
Journal:  Onco Targets Ther       Date:  2013-04-10       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.